KhabarCheckखबर चेक
← Top Stories

Starbucks ends employee coverage for these medicines amid rising US health costs

Limited reporting49

Starbucks will cease covering GLP-1 weight-loss drugs for employees starting October. This decision reflects rising costs and a broader employer trend in benefits. GLP-1 drugs, initially for diabetes, are now popular for obesity treatment. Other companies like Allina Health and PwC have also adju...

First seen · latest update · World · other

  • Indian mainstream 1
  • Indian independent 0
  • International 0
  • Official 0
Share

Coverage (1)

See a mistake? Wrong summary · Wrongly grouped · Missing source · Wrong category/region · Dispute outlet rating — each opens a pre-filled report on GitHub.